Boston & New England + Healthcare | April 16, 2021

BMS to Expand Lease at Cambridge Crossing by 113K SF

Pharmaceutical giant Bristol Myers Squibb has leased up the remaining portion of the nearly 480,000-square-foot life science building at DivcoWest’s Cambridge Crossing campus.

BMS expanded its initial 360,000-square-foot lease at DivcoWest’s 250 Water St. with an additional 113,000 square feet. The building is slated to deliver in 2022. Financial terms of the lease weren’t disclosed.

Cambridge Crossing was acquired by San Francisco-based DivcoWest for $291 million in 2015 and will also include 11 acres of open space as well as more than 2,400 residential units and retail space. The campus is located alongside the currently under-construction MBTA Green Line, which will include two new stops near the neighborhood.

Connect

Inside The Story

BMS

About David Cohen

David Cohen is Southeast Editorial Director at Connect Commercial Real Estate. David is a media veteran with more than 10 years of experience in journalism, copywriting and communications across a variety of roles. He is responsible for covering commercial real estate news and trends in the Southeast, Florida, Washington D.C. and Boston at Connect CRE as well as specializing in the Student Housing sector. Prior to joining Connect, David was the editor of Northeast Real Estate Business magazine and Student Housing Business magazine at France Media as well as spending time freelancing for ESPN and the Associated Press in the fast-paced field of live sports event production. He is also an owner and investor in multifamily real estate in Atlanta, GA. David currently resides in Atlanta and graduated from the College of Communication & Information at the University of Tennessee Knoxville.